177 related articles for article (PubMed ID: 19017985)
1. Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B.
Thio CL; Astemborski J; Thomas R; Mosbruger T; Witt MD; Goedert JJ; Hoots K; Winkler C; Thomas DL; Carrington M
J Immunol; 2008 Dec; 181(11):7944-7. PubMed ID: 19017985
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea.
Ahn SH; Kim DY; Chang HY; Hong SP; Shin JS; Kim YS; Kim H; Kim JK; Paik YH; Lee KS; Chon CY; Moon YM; Han KH
J Med Virol; 2006 Dec; 78(12):1564-71. PubMed ID: 17063508
[TBL] [Abstract][Full Text] [Related]
3. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
Thio CL; Astemborski J; Bashirova A; Mosbruger T; Greer S; Witt MD; Goedert JJ; Hilgartner M; Majeske A; O'Brien SJ; Thomas DL; Carrington M
J Virol; 2007 Jan; 81(2):441-5. PubMed ID: 17079285
[TBL] [Abstract][Full Text] [Related]
4. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
[TBL] [Abstract][Full Text] [Related]
5. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
Cheong JY; Cho SW; Choi JY; Lee JA; Kim MH; Lee JE; Hahm KB; Kim JH
J Korean Med Sci; 2007 Jun; 22(3):529-35. PubMed ID: 17596666
[TBL] [Abstract][Full Text] [Related]
6. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
Li H; Liu TJ; Hong ZH
Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
[TBL] [Abstract][Full Text] [Related]
7. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
[TBL] [Abstract][Full Text] [Related]
8. Prognostic, clinical, and therapeutic importance of RANTES-CCR5 axis in hepatitis A infection: A multiapproach study.
Baruah V; Tiwari D; Hazam RK; Bose M; Bujarbaruah D; Saikia AK; Kar P; Dutta S; Bose S
J Med Virol; 2021 Jun; 93(6):3656-3665. PubMed ID: 32975838
[TBL] [Abstract][Full Text] [Related]
9. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study.
McDermott DH; Beecroft MJ; Kleeberger CA; Al-Sharif FM; Ollier WE; Zimmerman PA; Boatin BA; Leitman SF; Detels R; Hajeer AH; Murphy PM
AIDS; 2000 Dec; 14(17):2671-8. PubMed ID: 11125885
[TBL] [Abstract][Full Text] [Related]
10. Distribution of functional polymorphic variants of inflammation-related genes RANTES and CCR5 in long-lived individuals.
Laplana M; Fibla J
Cytokine; 2012 Apr; 58(1):10-3. PubMed ID: 22265023
[TBL] [Abstract][Full Text] [Related]
11. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection].
Chang HY; Ahn SH; Kim DY; Shin JS; Kim YS; Hong SP; Chung HJ; Kim SO; Yoo WD; Han KH
Korean J Hepatol; 2005 Jun; 11(2):116-24. PubMed ID: 15980670
[TBL] [Abstract][Full Text] [Related]
12. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.
Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M
Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276
[TBL] [Abstract][Full Text] [Related]
13. Correlations between polymorphisms in the uridine diphosphate-glucuronosyltransferase 1A and C-C motif chemokine receptor 5 genes and infection with the hepatitis B virus in three ethnic groups in China.
Zhang C; He Y; Shan KR; Tan K; Zhang T; Wang CJ; Guan ZZ
J Int Med Res; 2018 Feb; 46(2):739-751. PubMed ID: 29239247
[TBL] [Abstract][Full Text] [Related]
14. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.
Fatima F; Saleem S; Hameed A; Haider G; Ali Zaidi SA; Kanwal M; Zehra S; Azhar A
Mol Biol Rep; 2019 Apr; 46(2):2387-2394. PubMed ID: 30848448
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism in the promoter of the CCL5 gene (CCL5G-403A) in a cohort of North Indian children with Kawasaki disease. A preliminary study.
Chaudhuri K; Singh Ahluwalia T; Singh S; Binepal G; Khullar M
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S126-30. PubMed ID: 21418786
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
Hellier S; Frodsham AJ; Hennig BJ; Klenerman P; Knapp S; Ramaley P; Satsangi J; Wright M; Zhang L; Thomas HC; Thursz M; Hill AV
Hepatology; 2003 Dec; 38(6):1468-76. PubMed ID: 14647058
[TBL] [Abstract][Full Text] [Related]
17. The effects of RANTES/CCR5 promoter polymorphisms on HIV disease progression in HIV-infected Koreans.
Jang DH; Choi BS; Kim SS
Int J Immunogenet; 2008 Apr; 35(2):101-5. PubMed ID: 18218038
[TBL] [Abstract][Full Text] [Related]
18. The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.
Goulding C; McManus R; Murphy A; MacDonald G; Barrett S; Crowe J; Hegarty J; McKiernan S; Kelleher D
Gut; 2005 Aug; 54(8):1157-61. PubMed ID: 15863470
[TBL] [Abstract][Full Text] [Related]
19. Do CCR5 (CCR5Δ32) and TLR3 (RS5743313) gene polymorphisms prevent chronic hepatitis B infection?
Tuncel B; Kaygusuz S; Sayın Kocakap DB; Aksoy E; Azkur AK
J Med Virol; 2023 Jan; 95(1):e28376. PubMed ID: 36478230
[TBL] [Abstract][Full Text] [Related]
20. [Study on the association between RANTES-403G/A as well as -28C/G gene polymorphism and their susceptibility to the hepatitis B virus infections in Dong and Han ethnicities in Guizhou, China].
Zhang C; Shan KR; He Y; Wang CJ; Zhang T; Li Y; Deng J; Li LJ; Ouyang K; Guan ZZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Dec; 33(12):1279-82. PubMed ID: 23336202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
